Procept BioRobotics Corp’s recent filing unveils that its President, CEO Zadno Reza unloaded Company’s shares for reported $0.26 million on Mar 18 ’24. In the deal valued at $48.83 per share,5,391 shares were sold. As a result of this transaction, Zadno Reza now holds 241,319 shares worth roughly $12.97 million.
Then, Waters Kevin sold 1,024 shares, generating $50,002 in total proceeds. Upon selling the shares at $48.83, the EVP, CFO now owns 102,149 shares.
Before that, Nouri Alaleh sold 441 shares. Procept BioRobotics Corp shares valued at $21,534 were divested by the EVP, CLO, CORP. SEC. at a price of $48.83 per share. As a result of the transaction, Nouri Alaleh now holds 62,472 shares, worth roughly $3.36 million.
Piper Sandler initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on August 11, 2023; the price target was $42. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. BTIG Research began covering PRCT with “Neutral” recommendation on October 31, 2022. Truist started covering the stock on October 25, 2022. It rated PRCT as “a Buy”.
Price Performance Review of PRCT
On Tuesday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock jump 5.00% to $53.75. Over the last five days, the stock has gained 3.39%. Procept BioRobotics Corp shares have risen nearly 28.25% since the year began. Nevertheless, the stocks have risen 47.30% over the past one year. While a 52-week high of $54.50 was reached on 04/11/24, a 52-week low of $24.83 was recorded on 01/05/24. SMA at 50 days reached $49.19, while 200 days put it at $39.51. A total of 0.62 million shares were traded, compared to the trading of 0.48 million shares in the previous session.
Levels Of Support And Resistance For PRCT Stock
The 24-hour chart illustrates a support level at 50.43, which if violated will result in even more drops to 47.12. On the upside, there is a resistance level at 55.63. A further resistance level may holdings at 57.52. The Relative Strength Index (RSI) on the 14-day chart is 62.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 8.39%. Stochastics %K at 68.79% indicates the stock is a holding.
The most recent change occurred on September 02, 2022 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $49 price target.
